Modulation of the resorption and osteoconductivity of α-calcium sulfate by histone deacetylase inhibitors

Biomaterials

Volumn 31, Issue 1, 2010, Pages 29-37

  Jung, Hong Moon ^a   Song, Gin Ah ^a   Lee, Yong Keun ^a   Baek, Jeong Hwa ^a   Ryoo, Hyun Mo ^a   Kim, Gwan Shik ^a   Choung, Phil Hoon ^b   Woo, Kyung Mi ^a  

^a Seoul National University   (South Korea)

^b School of Dentistry   (South Korea)

Author keywords

Alpha calcium sulfate; Bone regeneration; Histone deacetylase inhibitors; Osteoblasts; Osteoclasts

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; ALPHA CALCIUM SULFATE; BONE DEFECT; BONE FORMATION; BONE REGENERATION; BONE SIALOPROTEINS; CALCITONIN RECEPTORS; CALCIUM SULFATE; CALVARIAL MODEL; CLINICAL USE; CRITICAL SIZE; EXPRESSION LEVELS; HISTOLOGICAL ANALYSIS; HISTONE DEACETYLASE INHIBITOR; HISTONE DEACETYLASE INHIBITORS; MC3T3-E1; MICROCOMPUTED TOMOGRAPHY; OSTEOBLAST DIFFERENTIATION; OSTEOBLAST PHENOTYPE; OSTEOCALCIN; OSTEOCLASTIC DIFFERENTIATION; OSTEOCLASTS; OSTEOCONDUCTIVE MATERIALS; OSTEOCONDUCTIVITY; SETTING TIME; SIMULATED BODY FLUIDS; SODIUM BUTYRATE; TARTRATE-RESISTANT ACID PHOSPHATASE; TRICHOSTATIN A;

BODY FLUIDS; CALCIUM; CALCIUM ALLOYS; COMPRESSIVE STRENGTH; COMPUTERIZED TOMOGRAPHY; DISSOLUTION; NONVOLATILE STORAGE; OSTEOBLASTS; PROTEINS; SODIUM; TOMOGRAPHY;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; ALPHA CALCIUM SULFATE; BONE SIALOPROTEIN; BUTYRIC ACID; CALCITONIN RECEPTOR; CALCIUM SULFATE; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FLUID; BONE CONDUCTION; BONE DEFECT; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DISSOLUTION; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; MICRO-COMPUTED TOMOGRAPHY; MODULATION; MONOCYTE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; RAT; SIMULATION;

3T3 CELLS; ACID PHOSPHATASE; ANIMALS; BASE SEQUENCE; BONE AND BONES; CALCIUM SULFATE; CELL LINE; DNA PRIMERS; GENE EXPRESSION; HISTONE DEACETYLASE INHIBITORS; ISOENZYMES; MICE; RATS;

RATTUS;

EID: 70350549879     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.09.019     Document Type: Article

References (25)

1. Pietrzak W.S., and Ronk R. Calcium sulfate bone void filler: a review and a look ahead. J Craniofac Surg 11 (2000) 327-334
2. Thomas M.V., and Puleo D.A. Calcium sulfate: properties and clinical applications. J Biomed Mater Res Part B: Appl Biomater 88B (2009) 597-610
3. Rosenblum S.F., Frenkel S., Ricci J.R., and Alexander H. Diffusion of fibroblast growth factor from a plaster of Paris carrier. J Appl Biomater 4 (1993) 67-72
4. Rauschmann M.A., Wichelhaus T.A., Stirnal V., Dingeldein E., Zichner L., Schnettler R., et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26 (2005) 2677-2684
5. Lazary A., Balla B., Kosa J.P., Bacsi K., Nagy Z., Takacs I., et al. Effect of gypsum on proliferation and differentiation of MC3T3-E1 mouse osteoblastic cells. Biomaterials 28 (2007) 393-399
6. Mamidwar S.S., Arena C., Kelly S., Alexander H., and Ricci J. In vitro characterization of a calcium sulfate/PLLA composite for use as a bone graft material. J Biomed Mater Res Part B: Appl Biomater 81 (2007) 57-65
7. Woo K.M., Yu B., Jung H.M., and Lee Y.K. Comparative evaluation of different crystal-structured calcium sulfates as bone-filling materials. J Biomed Mater Res B Appl Biomater (2009) 10.1002/jbm.b.31428
8. de Boer J., Licht R., Bongers M., van der Klundert T., Arends R., and van Blitterswijk C. Inhibition of histone acetylation as a tool in bone tissue engineering. Tissue Eng 12 (2006) 2927-2937
9. Kelly W.K., and Marks P.A. Drug insight: histone deacetylase inhibitors-development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat Clin Pract Oncol 2 3 (2005) 150-157
10. Piekarz R., and Bates S. A review of depsipeptide and other histone deacetylase inhibitors in clinical trials. Curr Pharm Des 10 19 (2004) 2289-2298
11. Vanhaecke T., Papeleu P., Elaut G., and Rogiers V. Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr Med Chem 11 12 (2004) 1629-1643
12. Rahman M.M., Kukita A., Kukita T., Shobuike T., Nakamura T., and Kohashi O. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 101 (2003) 3451-3459
13. Yi T., Baek J.H., Kim H.J., Choi M.H., Seo S.B., Ryoo H.M., et al. Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis. Exp Mol Med 39 (2007) 213-221
14. Schroeder T.M., and Westendorf J.J. Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res 20 (2005) 2254-2263
15. Cho H.H., Park H.T., Kim Y.J., Bae Y.C., Suh K.T., and Jung J.S. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J Cell Biochem 96 (2005) 533-542
16. Wang M.L., Massie J., Perry A., Garfin S.R., and Kim C.W. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements. Spine J 7 (2007) 466-474
17. Aubin J.E., and Triffitt J.T. Mesenchymal stem cells and osteoblast differentiation. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of bone biology. 2nd ed. (2002), Academic Press, San Diego 59-82
18. Sidqui M., Collin P., Vitte C., and Forest N. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biomaterials 16 (1995) 1327-1332
19. Kim S.Y., Kim S.G., Lim S.C., and Bae C.S. Effects on bone formation in ovariectomized rats after implantation of tooth ash and plaster of Paris mixture. J Oral Maxillofac Surg 62 (2004) 852-857
20. Urban R.M., Turner T.M., Hall D.J., Infanger S.I., Cheema N., Lim T.H., et al. An injectable calcium sulfate-based bone graft putty using hydroxypropylmethylcellulose as the plasticizer. Orthopedics 27 (2004) s155-s159
21. Friedman C.D., Costantino P.D., Takagi S., and Chow L.C. BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res 43 4 (1998) 428-432
22. Tay B.K., Patel V.V., and Bradford D.S. Calcium sulfate- and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. Orthop Clin North Am 30 (1999) 615-623
23. Nilsson M., Fernández E., Sarda S., Lidgren L., and Planell J.A. Characterization of a novel calcium phosphate/sulphate bone cement. J Biomed Mater Res 61 4 (2002) 600-607
24. Bohner M. New hydraulic cements based on alpha-tricalcium phosphate-calcium sulfate dihydrate mixtures. Biomaterials 25 (2004) 741-749
25. Di Bernardo G., Squillaro T., Dell'Aversana C., Miceli M., Cipollaro M., Cascino A., et al. Histone deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. Stem Cells Dev 18 (2009) 573-581